<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03342040</url>
  </required_header>
  <id_info>
    <org_study_id>GemHRC</org_study_id>
    <nct_id>NCT03342040</nct_id>
  </id_info>
  <brief_title>Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair</brief_title>
  <official_title>Randomized Clinical Trial: Transverse Abdominis Plane Block Versus no Block in Laparoscopic Ventral Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GEM Hospital &amp; Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GEM Hospital &amp; Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study aims to determine if transverse abdominis plane block using local
      anesthetic agents (bupivacaine 0.25% + Ropivacaine 0.20%) decreases the post operative pain
      and helps in early mobilization or discharge from hospital in patients undergoing
      laparoscopic ventral hernia repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients meeting inclusion criteria would be randomised after admission. Those patients in
      experimental arm shall receive the TAP block under USG guidance while those in control arm do
      not receive any block. Surgery shall be proceeded in the usual manner in all the patients and
      assessment for pain starts in the immediate post operative or recovery room after the patient
      is completely conscious. The total amount of analgesic required by the patient is measured.
      Pain assessment is done using the visual analog scale (VAS) at regular intervals until follow
      up review.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 15, 2017</start_date>
  <completion_date type="Actual">February 1, 2019</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective double blinded balanced allocation, randomized clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participant and assessors are masked</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative cumulative analgesic requirement</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>The amount of analgesic required by the patient during hospital stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative hospital stay</measure>
    <time_frame>7 days from primary surgery</time_frame>
    <description>The time taken to get discharged from the hospital</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Ventral Hernia</condition>
  <arm_group>
    <arm_group_label>TAP block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing laparoscopic ventral hernia repair with TAP block with 0.2% ropivacaine under ultrasound guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No TAP block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergoing laparoscopic ventral hernia repair without TAP block</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic ventral hernia repair with TAP block</intervention_name>
    <description>Transverse abdominis plane block is given under ultrasound guidance during laparoscopic ventral hernia surgery</description>
    <arm_group_label>TAP block</arm_group_label>
    <other_name>Bupivacaine 0.25% and Ropivacaine 0.2% subcutaneous injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic ventral hernia repair without TAP block</intervention_name>
    <description>No block administered during Laparoscopic ventral hernia surgery</description>
    <arm_group_label>No TAP block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients undergoing laparoscopic ventral hernia repair during the study period

        Exclusion Criteria:

          -  Age &lt;15 or greater than 75 years

          -  ASA &gt; 3

          -  Obstructed , recurrent or strangulated hernia

          -  Lap assisted open hernia repair

          -  Patients undergoing component separation

          -  Parastomal hernia, spigelian hernia, lumbar hernia

          -  Patients with Chronic kidney disease, bronchial asthma

          -  Patients allergic to bupivacaine or NSAIDs

          -  Not willing to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>C C Palanivelu, MS, MCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gem Hospital and research center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gem hospital and research centre</name>
      <address>
        <city>Coimbatore</city>
        <state>Tamil Nadu</state>
        <zip>641015</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>September 29, 2017</study_first_submitted>
  <study_first_submitted_qc>November 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2017</study_first_posted>
  <last_update_submitted>February 13, 2019</last_update_submitted>
  <last_update_submitted_qc>February 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TAP block</keyword>
  <keyword>laparoscopic IPOM</keyword>
  <keyword>post operative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

